by ONS England | Jan 5, 2023 | VC19 (VACCINES COVID-19), VE (VACCINE EFFECTIVENESS), VS (VACCINE SAFETY)
Motivation Official ONS Data source for “NE-NS-expose-news.com-PfizerGate Tragic Truth behind COVID Vaccines 50k Brits have Died Suddenly in 8 Months due to Vaccination”. Conclusive evidence that Covid-19 “vaccines” are NOT EFFECTIVE and NOT...
by The Exposé, ONS England and Wales, PHS | Jan 5, 2023 | VC19 (VACCINES COVID-19), VE (VACCINE EFFECTIVENESS), VS (VACCINE SAFETY)
Motivation The Exposé: Strong evidence that Covid-19 “vaccinations” are NOT EFFECTIVE and that they are NOT SAFE. Independent press analysis of UK ONS data – with links to official sources. Analysis of Deaths by “Vaccination” Status and...
by Fernando P. Polack, S J Thomas, N Kitchin | Dec 20, 2022 | C19 (COVID-19), VC19 (VACCINES COVID-19), VE (VACCINE EFFECTIVENESS), VS (VACCINE SAFETY)
Motivation Supplementary appendix to the Pfizer phase 2/3 trial 2 month report – “Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine” published in the NEJM in December 2020. Author Polack FP, Thomas SJ, Kitchin N, et al. Submitted By Dr Herman...
by Fernando P. Polack, et al | Dec 20, 2022 | C19 (COVID-19), VC19 (VACCINES COVID-19), VE (VACCINE EFFECTIVENESS), VS (VACCINE SAFETY)
Motivation Pfizer vaccine phase 2/3 study, published in the NEJM in December 2020, that made the remarkable and misleading claim that the vaccine “was 95% EFFECTIVE in preventing Covid-19”. In fact the 95% was an EFFICACY calculation, based on the RRR of a...
by Pfizer, BioNTech | Dec 20, 2022 | C19 (COVID-19), VC19 (VACCINES COVID-19), VE (VACCINE EFFECTIVENESS), VS (VACCINE SAFETY)
Motivation PROTOCOL for Pfizer Phase 1/2 & 3 SARS-CoV-2 RNA Vaccine Trials. This specifies the trial design and rules. PF-07302048 (BNT162 RNA-Based COVID-19 Vaccines) Author Pfizer. BioNTech. Submitted By Dr Herman Edeling Supported By Dr Stephen Schmidt Type of...
by CCCA, Deanna McLeod | Dec 20, 2022 | VC19 (VACCINES COVID-19), VE (VACCINE EFFECTIVENESS), VS (VACCINE SAFETY)
Motivation Expert analysis of the Pfizer studies “Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine”, published in the NEJM. Serious flaws identified in trial design, conduct, data collection and reporting. Unblinding and crossover after 2 months....